Héctor Aviña

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang et al. · Cancer Research · 2016 · 696 citations

Pharmacy, Oncology, Pharmacology +17

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates

Hui Zhao, John Atkinson, Sara Gulesserian et al. · Cancer Research · 2018 · 133 citations

Medicine, Cell Biology, Oncology +11

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

Daniel S. Pereira, Claudia Guevara, Liqing Jin et al. · Molecular Cancer Therapeutics · 2015 · 97 citations

Medicine, Oncology, Pharmacology +17

Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia

Hui Zhao, Sara Gulesserian, Sathish Kumar Ganesan et al. · Molecular Cancer Therapeutics · 2017 · 70 citations · Full text

Medicine, Hematology, Pharmacology +14

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i> , a New Urothelial Cancer Biomarker

Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano et al. · Molecular Cancer Therapeutics · 2016 · 66 citations · Full text

Pharmacy, Oncology, Pharmacology +17